These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33763470)

  • 1. ABCA1-Labeled Exosomes in Serum Contain Higher MicroRNA-193b Levels in Alzheimer's Disease.
    Liu CG; Zhao Y; Lu Y; Wang PC
    Biomed Res Int; 2021; 2021():5450397. PubMed ID: 33763470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-135a in ABCA1-labeled Exosome is a Serum Biomarker Candidate for Alzheimer's Disease.
    Liu CG; Meng S; Li Y; Lu Y; Zhao Y; Wang PC
    Biomed Environ Sci; 2021 Jan; 34(1):19-28. PubMed ID: 33531104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer's disease.
    Liu CG; Song J; Zhang YQ; Wang PC
    Mol Med Rep; 2014 Nov; 10(5):2395-400. PubMed ID: 25119742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-β protein and MicroRNA-384 in NCAM-Labeled exosomes from peripheral blood are potential diagnostic markers for Alzheimer's disease.
    Li Y; Meng S; Di W; Xia M; Dong L; Zhao Y; Ling S; He J; Xue X; Chen X; Liu C
    CNS Neurosci Ther; 2022 Jul; 28(7):1093-1107. PubMed ID: 35470961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Serum Exosome Derived MicroRNA-135a, -193b, and -384 Were Potential Alzheimer's Disease Biomarkers.
    Yang TT; Liu CG; Gao SC; Zhang Y; Wang PC
    Biomed Environ Sci; 2018 Feb; 31(2):87-96. PubMed ID: 29606187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-29c-3p in dual-labeled exosome is a potential diagnostic marker of subjective cognitive decline.
    Li Y; Xia M; Meng S; Wu D; Ling S; Chen X; Liu C
    Neurobiol Dis; 2022 Sep; 171():105800. PubMed ID: 35752392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCA1-Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer's Disease.
    Yassine HN; Feng Q; Chiang J; Petrosspour LM; Fonteh AN; Chui HC; Harrington MG
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
    Liu CG; Wang JL; Li L; Wang PC
    Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
    Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
    Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.
    Riancho J; Vázquez-Higuera JL; Pozueta A; Lage C; Kazimierczak M; Bravo M; Calero M; Gonalezález A; Rodríguez E; Lleó A; Sánchez-Juan P
    J Alzheimers Dis; 2017; 57(2):483-491. PubMed ID: 28269782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic exosomal miR-193b-3p delivery attenuates neuroinflammation in early brain injury after subarachnoid hemorrhage in mice.
    Lai N; Wu D; Liang T; Pan P; Yuan G; Li X; Li H; Shen H; Wang Z; Chen G
    J Neuroinflammation; 2020 Feb; 17(1):74. PubMed ID: 32098619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-135a and -200b, potential Biomarkers for Alzheimer׳s disease, regulate β secretase and amyloid precursor protein.
    Liu CG; Wang JL; Li L; Xue LX; Zhang YQ; Wang PC
    Brain Res; 2014 Oct; 1583():55-64. PubMed ID: 25152461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer's Disease in APP/PS1 Transgenic Mouse.
    Hong H; Li Y; Su B
    J Alzheimers Dis; 2017; 59(4):1449-1458. PubMed ID: 28731435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal microRNA profiles from serum and cerebrospinal fluid in neurosyphilis.
    Chen H; Zhou Y; Wang ZY; Yan BX; Zhou WF; Wang TT; Zheng M; Man XY
    Sex Transm Infect; 2019 Jun; 95(4):246-250. PubMed ID: 30926713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concordance between the assessment of Aβ42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid.
    Jia L; Qiu Q; Zhang H; Chu L; Du Y; Zhang J; Zhou C; Liang F; Shi S; Wang S; Qin W; Wang Q; Li F; Wang Q; Li Y; Shen L; Wei Y; Jia J
    Alzheimers Dement; 2019 Aug; 15(8):1071-1080. PubMed ID: 31422798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer's Disease.
    De Felice B; Montanino C; Oliva M; Bonavita S; Di Onofrio V; Coppola C
    Mol Neurobiol; 2020 Nov; 57(11):4408-4416. PubMed ID: 32737762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Exosomal miR-223 Serves as a Potential Diagnostic and Prognostic Biomarker for Dementia.
    Wei H; Xu Y; Xu W; Zhou Q; Chen Q; Yang M; Feng F; Liu Y; Zhu X; Yu M; Li Y
    Neuroscience; 2018 May; 379():167-176. PubMed ID: 29559383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of miR-96-5p May Reduce Aβ42/Aβ40 Ratio via Regulating ATP-binding cassette transporter A1.
    Zhu M; Jia L; Jia J
    J Alzheimers Dis; 2021; 83(1):367-377. PubMed ID: 34334400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.
    Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
    Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.